Price$12.23-0.02 (-0.12%)
02:00 PM07:45 PM
News · 26 weeks40+325%
2025-12-072026-05-31
Mix3090d
- Insider13(43%)
- Other7(23%)
- SEC Filings7(23%)
- Earnings2(7%)
- Leadership1(3%)
Latest news
25 items- SECMEDIFAST INC filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - MEDIFAST INC (0000910329) (Filer)
- INSIDERDirector Rose Jeffrey Matthew was granted 18,419 shares (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERDirector Kiai Parsa was granted 19,317 shares (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERDirector Thomas Andrea B was granted 11,680 shares, increasing direct ownership by 49% to 35,697 units (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERDirector Schlackman Scott was granted 11,680 shares, increasing direct ownership by 38% to 42,229 units (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERDirector Geary Elizabeth A. was granted 11,680 shares, increasing direct ownership by 60% to 31,225 units (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERSEC Form 4 filed by Director Xian Ming4 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERSEC Form 3 filed by new insider Rose Jeffrey Matthew3 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERNew insider Kiai Parsa claimed ownership of 657,590 shares (SEC Form 3)3 - MEDIFAST INC (0000910329) (Issuer)
- SECMEDIFAST INC filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits8-K - MEDIFAST INC (0000910329) (Filer)
- PRMedifast Confirms Appointment of Nicholas Johnson as Chief Executive OfficerJohnson will succeed Dan Chard as CEO; Chard to remain Chairman of the Board Medifast, Inc. (NYSE:MED) today announced that its Board of Directors has formally appointed Nicholas Johnson as Chief Executive Officer, effective June 1, 2026. Johnson will succeed Dan Chard as CEO, who will continue to serve as Chairman of the Board. The appointment follows the leadership transition plan that the company disclosed in January and reflects the Board's confidence in Johnson's leadership and the company's strategic direction. Chard will remain actively engaged as Chairman of the Board, supporting Johnson and the leadership team while continuing to provide strategic oversight. "Nick has been a
- PRThe Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to DoA randomized controlled trial published in Obesity Science & Practice found that clients on the OPTAVIA Optimal Weight 5 & 1 Plan® who worked with a coach lost significantly more weight and fat than those who attempted the program without coaching support (Arterburn LM, et al., 2019)Higher retention in a weight management program is directly correlated with more significant weight loss outcomes, per a 2024 systematic review and meta-analysisOPTAVIA coaches complete a program-specific education curriculum and must pass a certification exam before supporting participantsIndependent research commissioned by OPTAVIA found that 96% of Americans recognize lifestyle changes are essential for weight
- PRWeight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes70% of users discontinued use of lifestyle behavior and health apps within the first 100 days (Kidman PG, et al., 2024)Early weight loss at week four is a strong predictor of clinically relevant outcomes, with research identifying additional counseling and support as key for those showing lower early progress (Coleman CD, et al., 2023)Accountability and self-monitoring are among the most commonly reported factors in sustaining weight loss results, according to a research survey of OPTAVIA coaches and clients (Coleman CD, et al., 2022)In a peer-reviewed clinical trial, participants working with a coach lost up to 10 times more weight and 17 times more fat, and achieved a 14% reduction in visc
- PRPeer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass PreservationBody composition, specifically visceral fat levels and lean mass, plays a meaningful role in long-term metabolic health (Serra MC, et al., 2019)Structured plans, habit building, and dedicated coach support work together to produce body composition outcomes that reflect the quality of weight loss, not just its quantity (Arterburn LM, et al., 2019)High-quality protein, nutrient density, and scientifically developed nutrition, combined with structured plans and habit building, support visceral fat reduction and lean mass preservation during weight loss Human accountability and coach support can lead to stronger outcomes in sustained behavior change and weight management success (Arterburn LM, e
- PRPeer-Reviewed Research Is Redefining Weight Loss Program StandardsThe global weight loss industry was valued at $16.3 billion in 2025, yet peer-reviewed clinical validation of program outcomes remains uneven across the categoryRandomized controlled trials control for the lifestyle variables and selection bias that self-reported program data cannot account for, making them the standard for evaluating whether a weight loss program itself is driving outcomesBody composition is the breakdown of fat, lean mass, and bone. It shows what weight loss is actually made up of, a distinction that scale weight alone cannot captureA coach can address the specific barriers that may cause program adherence to stall, providing an additional support compared to digital track
- SECAmendment: SEC Form SCHEDULE 13G/A filed by MEDIFAST INCSCHEDULE 13G/A - MEDIFAST INC (0000910329) (Subject)
- INSIDERDirector Schlackman Scott bought $62,950 worth of shares (5,000 units at $12.59), increasing direct ownership by 20% to 30,549 units (SEC Form 4)4 - MEDIFAST INC (0000910329) (Issuer)
- SECSEC Form 10-Q filed by MEDIFAST INC10-Q - MEDIFAST INC (0000910329) (Filer)
- SECMEDIFAST INC filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - MEDIFAST INC (0000910329) (Filer)
- PRMedifast Announces First Quarter 2026 Financial ResultsMedifast (NYSE:MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the first quarter ended March 31, 2026. First Quarter 2026 Revenue of $76.0 million, with revenue per active earning coach of $5,432 Independent active earning coaches of 14,000 Net loss of $2.1 million, or $0.19 per diluted share ("EPS") Cash, Cash Equivalents, and Investment Securities of $168.9 million with no debt "We are encouraged by the continued progress we are seeing as we execute our metabolic health strategy, including a second consecutive quarter of year-over-year coach productivity growth, strong coach leadership
- PRMedifast to Announce Financial Results for the First Quarter Ended March 31, 2026Medifast (NYSE:MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter ended March 31, 2026 on Monday, May 4, 2026, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, Nick Johnson, President, and Jim Maloney, Chief Financial Officer. The conference call is scheduled to begin at 4:30 p.m. ET on May 4, 2026. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast's website at www.MedifastInc.com or
- SECSEC Form DEF 14A filed by MEDIFAST INCDEF 14A - MEDIFAST INC (0000910329) (Filer)
- SECSEC Form DEFA14A filed by MEDIFAST INCDEFA14A - MEDIFAST INC (0000910329) (Filer)
- INSIDERSEC Form 3 filed by new insider Johnson Nicholas Mark3 - MEDIFAST INC (0000910329) (Issuer)
- INSIDERSEC Form 4 filed by Mackenzie Jonathan Barrett4 - MEDIFAST INC (0000910329) (Issuer)
MED FAQ
6 questionsWhat does MEDIFAST INC do?
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through point of sale transactions over ecommerce platform and...Where does MED stock trade?
MEDIFAST INC (MED) is listed on NYSE.What sector and industry is MED in?
MEDIFAST INC operates in the Consumer Staples sector, Packaged Foods industry.What are analysts saying about MED?
MEDIFAST INC has had 7 recent analyst actions on file. The most recent action was from DA Davidson: Neutral with a $1700.00 price target on 2024-11-05. Recent price targets range from $1700.00 to $1750.00.What companies are similar to MED?
Notable peers in the same industry include MDLZ (Mondelez International Inc.), ADM (Archer-Daniels-Midland Company), KHC (The Kraft Heinz Company), BG (Bunge Limited), K (Kellanova). Compare MED side-by-side with any of them on Quantisnow.How can I track MED on Quantisnow?
Quantisnow aggregates MEDIFAST INC's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MED to receive live email and push alerts on every new disclosure.